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The color of turmeric (薑黃 jiang huang) is because of a substance called curcumin. It has different
pharmacological effects, such as antioxidant and anti-inﬂammatory properties. Nicotine is a major
pharmacologically active substance in cigarette smoke. It is mainly metabolized in the liver and causes
devastating effects. This study was designed to evaluate the protective role of curcumin against nicotine
on the liver in mice.
Forty-eight mice were equally divided into eight groups; control (normal saline), nicotine (2.5 mg/kg),
curcumin (10, 30, and 60 mg/kg) and curcumin plus nicotine-treated groups. Curcumin, nicotine, and
curcumin plus nicotine (once a day) were intraperitoneally injected for 4 weeks. The liver weight and
histology, aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP),
and serum nitric oxide levels have been studied.
The results indicated that nicotine administration signiﬁcantly decreased liver weight and increased
the mean diameter of hepatocyte, central hepatic vein, liver enzymes level, and blood serum nitric oxide
level compared with the saline group (p < 0.05). However, curcumin and curcumin plus nicotine
administration substantially increased liver weight and decreased the mean diameter of hepatocyte,
central hepatic vein, liver enzymes, and nitric oxide levels in all groups compared with the nicotine
group (p < 0.05).
Curcumin demonstrated its protective effect against nicotine-induced liver toxicity.
Copyright © 2014, Center for Food and Biomolecules, National Taiwan University. Production and hosting
by Elsevier Taiwan LLC. All rights reserved.1. Introduction
A large and increasing number of patients in the world use
medicinal plants and herbs for health purposes.1 Curcuma longa
(turmeric; 薑黃 jiang huang), one of the oldest plants, belongs to
the Zingiberaceae family, which has long been used in traditional
medicine for blood puriﬁcation, digestion, arthritis treatment, liver
protection, and as an anti-inﬂammatory agent.2 The color of
turmeric is because of a chemical called curcumin, which comprises
3e4% of tumeric.3 Numerous studies have reported the antioxidant
properties, anti-mutation and antitumor effects, and carcinogenicesearch Center, Kermanshah
for Food and Biomolecules,
molecules, National Taiwan Univecharacteristics of curcumin.4 Curcumin affects the metabolism of
arachidonic acid by inhibiting the phosphorylation of phospholi-
pase A2 (PLA2), decreasing the expression of cyclooxygenase
(COX)-2 gene and inhibiting the catabolic activity of COX-5. These
effects induce the anti-inﬂammatory activity of curcumin.5 In
addition, curcumin decreases the expression of different inﬂam-
matory cytokines such as interleukin (IL)-1, tumor necrosis factor
(TNF)- a, IL-6, and chemokines.6 Curcumin shows efﬁcacy in pro-
moting wound healing as well as treating liver ailments, urinary
tract diseases, and hepatitis.7 Pharmacologically, curcumin exhibits
a wide range of effects including anti-inﬂammatory, hypo-choles-
terolemic, and anti-infection activities and as well as anticarcino-
genic effects.8,9 Although approximately 4000 components are
present in the cigarette, nicotine is a highly toxic organic compound
containing nitrogen and alkaloid, which are mostly found in to-
bacco, and it is responsible for some of the deleterious effects of
smoking.10 Nicotine affects a variety of cellular processes including
altered gene expression.11 Exposure to nicotine produces oxidativersity. Production and hosting by Elsevier Taiwan LLC. All rights reserved.
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glutathione content and a decrease in the activity of some oxygen
free radical scavengers, such as catalase and superoxide dismut-
ase.12 The liver is considered to be the major site of nicotine
biotransformation, and nicotine exerts a number of adverse phys-
iological effects on the liver.13 Nicotine is absorbed through the
lungs during smoking and is rapidly metabolized in the liver, which
induces three major adverse effects on the liver: toxic (direct or
indirect), immunological, and oncogenic.14 Smoking causes liver
cell injury and exerts genotoxic effects on rat liver.15 Current studies
on curcumin effects have not reported on the protective effect of
curcumin against nicotine; therefore, the current study was con-
ducted to analyze the protective effect of curcumin to offset the
damage induced by nicotine in the liver of male mice.
2. Materials and methods
2.1. Chemicals
Curcumin (4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-
dione; C21H20O6) powder (Merck, Germany) was purchased, The
powder was dissolved in absolute ethanol (C2H5OH) and diluted
with normal saline (0.9%) to prepare different doses. Also, the
nicotine solution (1-metyl-2-3-pyridel-pirolidin; C10H14N2,
Merck, Germany) was also purchased and was diluted by normal
saline (0.9%) for administration (Fig. 1).
2.2. Experimental protocol
The mice were randomly divided into eight groups of six: con-
trol group (normal saline; 1 mL distilled water/daily); nicotine-
treated group (2.5 mg/kg); 3) nicotine þ curcumin 10 mg/kg
treated group; nicotine þ curcumin 30 mg/kg treated group;
nicotine þ curcumin 60 mg/kg treated group; curcumin 10 mg/kg
treated group; curcumin 30 mg/kg treated group; and curcumin
60 mg/kg treated group. Nicotine was administered intraperito-
neally once a day for 4 weeks. Curcumin and nicotine plus curcu-
min were administered intraperitoneally in animals.16e18
2.3. Animals
Forty-eight Balb/c malemicewithweight range of 27e30 gwere
purchased from Tehran Razi Institute. Animals were kept at the
temperature of 22 ± 2C, under controlled environmental condi-
tions, 12/12 hours light/dark cycle and free access to water and
food. Maintenance and care of experimental animals complies with
National Institutes of Health guidelines.19 Experiments were
designed to conform with the International Guiding Principles for
Biomedical Research Involving Animals (1985).
2.4. Liver weight and collection of blood serum
At the end of the experimental period, all animals were deeply
anesthetized with ether. Blood was collected from the right
ventricle, and serum separated and stored at 80C forFig. 1. Structure of nicotine and curcumin.measurement of nitric oxide. They were then killed. Livers were
removed and weighed on a microbalance sensitive to 0.001 mg
(Precisa 125A, Switzerland) and recorded.20
2.5. Histological analysis
For the histological evaluation of the hepatic structures, the
lower 1-cm-long part of the right lobe of the liver in transverse
pieces was removed, washed in saline, and ﬁxed in 10% formalin at
room temperature for 72 hours. After tissue ﬁxation, it was thor-
oughly washed under running water and dehydrated in ascending
concentration ethanol, cleared in xylene, and then embedded in
soft parafﬁn. Thin sections (5 mm) were cut using a microtome
(Leica RM 2125, LeicaMicrosystems Nussloch GmbH, Germany) and
stained with hematoxylin and eosin. The preparation was exam-
ined with an Olympus BX-51T-32E01 research microscope con-
nected to a DP12 Camera with 3.34-million pixel resolution and
Olysia Bio software (Olympus Optical Co. LTD, Tokyo, Japan).21
2.6. Morphometric measurements
For each hepatocyte, the total cellular area was measured. The
outline of each hepatocyte was measured after taking an image
with a 40  objective lens. The longest and shortest axis were
measured in the drawing of each hepatocyte in order to estimate
the mean diameter (mean axis). At least 50 hepatocytes from each
zone (total, 100) were measured in each liver. A separate mea-
surement for central hepatic vein was performed, using the same
methodology.22,23
2.7. Griess assay
Nitric oxide was measured based on Griess colorimetric assay.
Accordingly, N-1-naphthylenediamine (NEED), sulfonamide solu-
tions, and nitrite standards were prepared. To measure nitrite
concentration in serum, after defreezing the serum samples, 100 mL
of the sample serum was deproteinized by zinc sulfate and trans-
ferred to the wells. One hundred microliters of chloride vanadium,
50 mL sulfonamide, and 50 mL NEED solutions were added after-
ward. The samples were incubated in the temperature of 30C in
darkness. The optical density of samples was measured using an
enzyme-linked immunosorbent assay reader (Hyperion, Germany)
at the wavelength of 540 nm.24
2.8. Biochemical analysis
The liver was minced and homogenized (10% w/v) in ice-cold
0.1M sodium phosphate buffer (pH 7.4). The homogenate was
centrifuged twice at 10,000 rpm for 15 to 20 min at 4C to obtain
enzyme fraction. The resultant supernatant was used for various
biochemical assays. Activities of aspartate aminotransferase (AST)
and alanine aminotransferase (ALT) were assayed using themethod
of Reitman and Frankel.25 Activities of alkaline phosphatase (ALP)
were determined according to the protocol described in the labo-
ratory practical manual.26
2.9. Statistical analysis
All the quantitative data were presented as mean ± standard
deviation. One-way analysis of variance followed by least signiﬁ-
cant difference post hoc test were performed to determine the
statistical signiﬁcance between different groups using SPSS soft-
ware package 16.0 (Statistical Package for the Social Sciences,
version 16.0, SPSS Inc, Chicago, Illinois, USA). A p value <0.05 was
considered signiﬁcant.
Fig. 2. *Signiﬁcant decrease of liver weight in the nicotine group compared with the saline group (p < 0.05). **Signiﬁcant increase in all groups of curcumin compared with the
nicotine group (p < 0.05). ***Signiﬁcant increase all groups of curcumin-nicotine compared with the nicotine group (p < 0.05).
Fig. 3. (E) *Signiﬁcant increase of the mean hepatocytes diameter in the nicotine group compared with the saline group (p < 0.05). **Signiﬁcant decrease in all groups of curcumin
administration compared with the nicotine group (p < 0.05). ***Signiﬁcant decrease in all groups of curcumin-nicotine administration compared with the nicotine group (p < 0.05).
(A) Saline group. (B) Nicotine group. (C) Curcumin 60 mg/kg. (D) Curcumin (60 mg/kg) plus nicotine (magniﬁcation 100).
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3.1. Liver weight
In the current study, the effective dose of nicotine (2.5 mg/kg)
caused a signiﬁcant decrease in the liver weight of the mice
compared with the saline group (p < 0.05). Moreover, liver weight
was signiﬁcantly decreased in animals treated with curcumin and
curcumin plus nicotine in all doses in comparisonwith the nicotine
group (p < 0.05) (Fig. 2).
3.2. Morphometric measurements
The mean diameter of hepatocytes and central hepatic vein was
substantially increased in the nicotine administration group in
comparisonwith the saline group (p < 0.05). Further, curcumin and
curcumin plus nicotine caused a signiﬁcant decrease in the meanFig. 4. (E) *Signiﬁcant increase of the mean central hepatic vein diameter in the nicotine gr
curcumin administration compared with the nicotine group (p < 0.05). ***Signiﬁcant decrea
(p < 0.05). (A) Saline group. (B) Nicotine group. (C) Curcumin 60 mg/kg. (D) Curcumin (60diameter of hepatocytes and central hepatic vein in all treated
groups in comparisonwith nicotine group administration (p < 0.05)
(Figs. 3 and 4).
3.3. Nitric oxide
The mean nitric oxide in blood serum increased signiﬁcantly
(2.5 mL/kg) in the nicotine group in comparison with the saline
group (p < 0.05). Also, the mean nitric oxide in blood serum
decreased signiﬁcantly in curcumin and curcumin plus nicotine in
all groups in comparison with the nicotine group (Fig. 5).
3.4. Biochemical analysis
Nicotine (2.5 mL/kg) caused a signiﬁcant increase in themean of
ALT, AST, and ALP enzymes compared with the saline group
(p < 0.05). In addition, the mean of ALT, AST, and ALP enzymesoup compared with the saline group (p < 0.05). **Signiﬁcant decrease in all groups of
se in all groups of curcumin-nicotine administration compared with the nicotine group
mg/kg) plus nicotine (magniﬁcation 100).
Fig. 5. *Signiﬁcant increase of nitric oxide in the nicotine group compared with the saline group (p < 0.05). **Signiﬁcant decrease in all groups of curcumin administration
compared with the nicotine group (p < 0.05). ***Signiﬁcant decrease in all groups of curcumin-nicotine administration compared with the nicotine group (p < 0.05).
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all groups in comparisonwith the nicotine group (p < 0.05) (Figs. 6,
7, and 8).
Liver damage induced by Nicotine administration included
histological changes of liver conﬁrmed by hematoxylin and eosin
staining (Fig. 9).
4. Discussion
The liver is an organ that plays a signiﬁcant role in the oxidation
of fatty acids and carbohydrates.13 Curcumin, with its high antiox-
idant power, exerts its protective effect on the liver.27 Moreover,
curcumin can have protective effects on lipid peroxidation in rat
liver in oxidative stress conditions, can collect free radicals, and can
increase intracellular glutathione levels.27 The current study
investigated the protective effects of curcumin against the disor-
ders induced by nicotine administration, which affected liver
weight, diameter of hepatocytes and central vein, serum level ofFig. 6. *Signiﬁcant increase of alanine aminotransferase (ALT) enzyme in the nicotine gro
curcumin compared with nicotine group administration (p < 0.05). ***Signiﬁcant decreaseliver enzymes (AST, ALT, and ALP), and nitric oxide secretion level.
In the current study, nicotine administration signiﬁcantly increased
the serum level of AST, ALT, and ALK enzymes in comparison with
the control group, which mostly approached the normal level with
curcumin administration. Necrosis or cell membrane damage can
cause the release of these enzymes into blood. However, the serum
level of these enzymes is associated with liver performance.28 It
seems that nicotine causes the destruction of hepatic cell mem-
brane, thereby releasing cytozomal enzymes of hepatocytes and
ﬁnally increasing their serum level.29 In the groups that received
curcumin, the amount of these enzymes was reduced, which in-
dicates the protective effects of curcumin against the toxicity
induced by nicotine. The obtained results may be due to the anti-
oxidant effects and reduction of oxidative stress in curcumin.30
Further, because TNF-a and IL-1 play a role in the induction of
hepatic necrosis, curcumin can reduce the effects of toxicity by
inhibiting the secretion of TNF-a and IL-1 by macrophages.31 The
ﬁndings of the current studywere in linewith the results of Fu et al,up compared with the saline group (p < 0.05). **Signiﬁcant decrease in all groups of
all groups of curcumin -nicotine compared with the nicotine group (p < 0.05).
Fig. 7. *Signiﬁcant increase of aspartate aminotransferase (AST) AST enzyme in the nicotine group compared with the saline group (p < 0.05). ** Signiﬁcant decrease in all groups of
curcumin compared with nicotine group administration (p < 0.05). *** Signiﬁcant decrease in all groups of curcumin-nicotine compared with the nicotine group (p < 0.05).
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patic enzyme due to Chemokine (CeC motif) ligand 4 (CCl4)
administration.32 The results of liver weight analysis showed a
signiﬁcant decrease in liver weight between the nicotine and
control (saline) groups; however, liver weight increased after cur-
cumin administration in comparison with the nicotine group. The
metabolic disorders in rats caused by nicotine administration
might cause the weight loss, which was largely compensated by
curcumin administration33 The results of the current study were
also in agreement with the ﬁndings of Chuang et al, who reported
curcumin as the factor to increase liver weight.34 Moreover, the
results conﬁrmed the ﬁndings of the study carried out by Willis
et al, in which nicotine was reported to reduce the weight of
different organs, including the liver.35 The histopathological results
obtained in this study revealed the increase in diameter of mean
hepatocytes and central veins due to nicotine administration. The
change in the size of hepatocytes and central veins seems to be the
result of an increase in the metabolic activity of cells to excreteFig. 8. *Signiﬁcant increase of alkaline phosphatase (ALP) enzyme in the nicotine group com
compared with nicotine group administration (p < 0.05). ***Signiﬁcant decrease in all groutoxins from the body during the toxiﬁcation process.36 It seems that
free radicals induced by nicotine metabolism trigger lipid peroxi-
dation and reaction to DNA and membrane proteins, thereby
causing cell damage.37 Antioxidant compounds such as curcumin
can induce inhibitory effects on cytochrome P450, prevent nicotine
metabolism, and consequently reduce the production of free radi-
cals.38 Tetrahydro curcumin is one of the most important metab-
olites of curcumin and an active biological component of turmeric
(薑黃 jiang huang) in the cytosol of hepatic cells. This substance
seems to have extensive antioxidant activities in both in vitro and
in vivo conditions.39 The ﬁndings of this study were also in linewith
the results of the study by Su~ner et al, in which they reported
nicotine administration resulted in increased size and vascularity of
choroidal neovascularization.40 The results obtained from the
measurement of nitric oxide in blood indicated a signiﬁcant in-
crease between the nicotine and control (saline) groups; however,
nicotine administration reduced nitric oxide level. Nitric oxide is a
free radical that is produced inmammalian cells and interfereswithpared with the saline group (p < 0.05). **Signiﬁcant decrease in all groups of curcumin
ps of curcumin-nicotine compared with the nicotine group (p < 0.05).
Fig. 9. Histological changes of liver hematoxylin-eosin staining. (A) Nicotine group. Arrows point to the histological changes of nicotine administration, Blue arrow pointing to
lymphocytic inﬁltration and Yellow arrow pointing to enlargement of central hepatic vein (B) Saline group (control).
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associated with induction of various diseases.41 The hydroxyl rad-
icals produced by nitric oxide seem to interfere with the patho-
genesis process and hepatic toxicity.42 Nicotine can induce the
release of noradrenalin in paraventricular nucleus and amygdala
through direct effect on the nuclei of solitary tract and N-methyl-D-
aspartate receptors, which in turn stimulate the production of nitric
oxide and noradrenergic activity of neurons.43 Nicotine absorption
in the body seems to be followed by the increase of serum nitric
oxide level and oxidative stress.43 Curcumin is structurally a poly-
phenol and exerts a protective effect on lipid oxidation in the liver
in oxidative stress conditions, and acts as a collector of free radicals
of oxygen and enhancer of intracellular glutathione.44 Thus, it can
destroy the nitric oxide system (protein enzymes, substrates, and
cofactors) and reduce nitric oxide production.42 The results of the
study conducted by Zhao et al indicated that nicotine can decrease
angiogenesis in gastric mucosa through inhibition of nitric oxide
production and prevention of new cells' production process,45
which are in contrast with the ﬁndings obtained in the current
study. However, the results of the current study conﬁrm the ﬁnd-
ings of Muller and Schepers, showing the increase of peroxynitrite
formation due to cigarette smoke, an element known to damage
DNA.46
5. Conclusion
The current investigation demonstrates that nicotine has the
potential to cause substantial damage in liver tissues and curcumin
may improve some of this liver damage in mice. Therefore, curcu-
min could be useful to protect the liver from nicotine toxicity. The
antioxidant effects of curcumin may be a major reason for its
positive effect on liver parameters. However, further studies are
required to deﬁne its exact mechanism of action.
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